In cholangiocarcinoma, WDR5 modification changes are promoted by using FGF2 stimulation or constructing FGFR2 fusion mutations, or by using inhibitors to inhibit FGFR2 function
收藏integrated proteome resources2026-02-07 收录
官方服务：
资源简介：
In cholangiocarcinoma, WDR5 modification changes are promoted by using FGF2 stimulation or constructing FGFR2 fusion mutations, or by using inhibitors to inhibit FGFR2 function
创建时间：
2024-05-28
